Core Facilities

The centre was established in July 2022 and is led by Associate Professor Paul A. MacAry, Director of Life Sciences Institute (LSI), at the National University of Singapore (NUS) and Professor Ken Smith, Director of Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), at the University of Cambridge. NCIPC is an advanced, comprehensive immune, metabolic and microbial phenotyping platform that exploits advances in high-dimensional flow cytometry, massive parallel sequencing, microbiome metagenomics, proteomics, and single-cell transcriptomics to map cellular and molecular pathways in human health and disease and in patients with a range of diseases and subject to various therapeutic interventions.

The platform at NUS is a mirror-image to the Cambridge BRC Cell Phenotyping Hub at the University of Cambridge. Both sites have identical equipment, methods and workflows, in order to simultaneously run and generate standardised data that can be directly comparable to cohort studies at both sites. The centre serves as a focal point for research collaborations between basic and clinician scientists and industries aiming to investigate Asian and Caucasian phenotypes within Singapore and Cambridge. The centre is managed by Dr Karishma Sachaphibulkij and a scientific team of experts.